HOME › DRUGS › LOPINAVIR
ACTIVE SUBSTANCE / INN

LOPINAVIR

Brand name(s): LOPINAVIR AND RITONAVIR, LOPINAVIR; RITONAVIR, KALETRA
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
NDA205425
NDA021251
ACTIVE SUBSTANCE
Lopinavir
REGULATORS
FDA
SPONSORS / MAH
MYLAN PHARMA, CIPLA LTD, ABBVIE
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LOPINAVIR; RITONAVIRANDA091202MYLAN PHARMANone (Tentative Approval)
LOPINAVIR AND RITONAVIRANDA204739MACLEODS PHARMS LTDPrescription
LOPINAVIR AND RITONAVIRNDA205425CIPLA LTDNone (Tentative Approval)
KALETRANDA021226ABBVIEDiscontinued
KALETRANDA021251ABBVIEPrescription
LOPINAVIR AND RITONAVIRANDA207407LANNETT CO INCDiscontinued

FULL INTELLIGENCE ON LOPINAVIR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →